# Palvella Therapeutics, Inc. (PVLA)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/PVLA/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -37.64M | $ -23.71M | N/A | $ 216.87M |
| 2025 | $ 0 | $ -42.71M | $ -25.60M | N/A | $ 27.98M |
| 2024 | $ 0 | $ -18.32M | $ -8.51M | $ 0 | $ 62.61M |
| 2023 | $ 46.29M | $ -26.54M | $ -36.12M | $ 0 | $ 26.76M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Liabilities / Eq | 0.17 |
| Current Ratio | 21.18 |

## Other views

- [Metrics](https://sponda.capital/en/PVLA.md)
- [Charts](https://sponda.capital/en/PVLA/charts.md)
- [Compare](https://sponda.capital/en/PVLA/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.